Monthly Archives: January 2024

STEMCELL Technologies Announces Acquisition of Propagenix Inc.

2024-05-27T10:52:50-07:00January 19th, 2024|Categories: Uncategorized|

“The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada’s biotechnology industry,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Propagenix’s technology has the potential to contribute to big advancements in scientific research in both labs and clinical settings for the treatment of cancer, airway diseases, and other disorders, and we are thrilled to welcome its portfolio into STEMCELL’s product suite.” READ THE FULL ARTICLE

Go to Top